This Article Full Text Full Text (PDF) All Versions of this Article: 17/6/1066    most recent Author Manuscript (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Binart, N. Articles by Kelly, P. A. Search for Related Content PubMed PubMed Citation Articles by Binart, N. Articles by Kelly, P. A. Pubmed/NCBI databases Gene GEO Profiles HomoloGene UniGene Substance via MeSH

A Short Form of the Prolactin (PRL) Receptor Is Able to Rescue Mammopoiesis in Heterozygous PRL Receptor Mice

Hormone Targets (N.B., P.I.-B., N.B., P.A.K.), Institut National de la Santé et de la Recherche Médicale Unit 584, Faculté de Médecine Necker-Enfants Malades, 75730 Paris, France; and Unité de Différenciation Cellulaire (C.V.), Institut National de la Recherche Agronomique, 78352 Jouy en Josas, France

Address all correspondence and requests for reprints to: Nadine Binart, Hormone Targets, Institut National de la Santé et de la Recherche Médicale, Unité 584, Faculté de Médecine Necker, 156 rue de Vaugirard, 75730 Paris, France. E-mail: binart{at}necker.fr.

The heterozygous prolactin (PRL) receptor (PRLR +/-) mouse fails to develop a fully functional mammary gland at the end of the first pregnancy and shows markedly impaired lobuloalveolar development and milk secretion in young females. The PRLR is expressed ubiquitously, with various proportions of long and short isoforms in different tissues. Conflicting data have appeared on the putative role of the receptor short forms, with both agonist and antagonistic actions proposed. To assess whether the mouse PR-1 short isoform of the PRLR is potentially able to transduce a signal, we overexpressed it in heterozygous mice and investigated its effect on the rescue of mammary development. PRLR+/- mice were not able to develop a functional mammary gland, but restoration of mammary alveolar development and an increase in the expressions of casein and whey acidic protein genes were observed in transgenic PRLR+/- mice expressing the short form of the PRLR, leading to a complete rescue of mammary gland development and function in young females. These results demonstrate that PR-1, the short form of the PRLR, can improve mammary development in PRLR+/- mice, which compensates for the haploinsufficiency of the receptor long form; this effect is probably caused by accelerated proliferation and an activation of the PRLR signaling cascade, resulting in activation of target genes involved in mammary development and milk synthesis.

This article has been cited by other articles:

				N. Ben-Jonathan, C. R. LaPensee, and E. W. LaPensee What Can We Learn from Rodents about Prolactin in Humans? Endocr. Rev., February 1, 2008; 29(1): 1 - 41. [Abstract] [Full Text] [PDF]

				J. Halperin, S. Y. Devi, S. Elizur, C. Stocco, A. Shehu, D. Rebourcet, T. G. Unterman, N. D. Leslie, J. Le, N. Binart, et al. Prolactin Signaling through the Short Form of Its Receptor Represses Forkhead Transcription Factor FOXO3 and Its Target Gene Galt Causing a Severe Ovarian Defect Mol. Endocrinol., February 1, 2008; 22(2): 513 - 522. [Abstract] [Full Text] [PDF]

				A. Bachelot and N. Binart Reproductive role of prolactin Reproduction, February 1, 2007; 133(2): 361 - 369. [Abstract] [Full Text] [PDF]

				I. El Khattabi, C. Remacle, and B. Reusens The regulation of IGFs and IGFBPs by prolactin in primary culture of fetal rat hepatocytes is influenced by maternal malnutrition Am J Physiol Endocrinol Metab, October 1, 2006; 291(4): E835 - E842. [Abstract] [Full Text] [PDF]

				M. J. Naylor, S. R. Oakes, M. Gardiner-Garden, J. Harris, K. Blazek, T. W. C. Ho, F. C. Li, D. Wynick, A. M. Walker, and C. J. Ormandy Transcriptional Changes Underlying the Secretory Activation Phase of Mammary Gland Development Mol. Endocrinol., July 1, 2005; 19(7): 1868 - 1883. [Abstract] [Full Text] [PDF]

				V. Goffin, S. Bernichtein, P. Touraine, and P. A. Kelly Development and Potential Clinical Uses of Human Prolactin Receptor Antagonists Endocr. Rev., May 1, 2005; 26(3): 400 - 422. [Abstract] [Full Text] [PDF]

				W. Ruan, M. E. Monaco, and D. L. Kleinberg Progesterone Stimulates Mammary Gland Ductal Morphogenesis by Synergizing with and Enhancing Insulin-Like Growth Factor-I Action Endocrinology, March 1, 2005; 146(3): 1170 - 1178. [Abstract] [Full Text] [PDF]

				T. L. Auchtung, A. G. Rius, P. E. Kendall, T. B. McFadden, and G. E. Dahl Effects of Photoperiod During the Dry Period on Prolactin, Prolactin Receptor, and Milk Production of Dairy Cows J Dairy Sci, January 1, 2005; 88(1): 121 - 127. [Abstract] [Full Text] [PDF]